EXE — Extendicare Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeMid CapSuper Stock

Annual cashflow statement for Extendicare, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	C2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	54.2	11.5	69.6	34	75.2
Depreciation
Deferred Taxes
Non-Cash Items	42.5	46.4	-49.4	14.9	33.8
Discontinued Operations
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-9.17	-31.1	49.3	-61.8	4.11
Change in Accounts Receivable
Change in Other Assets
Change in Payable / Accrued Expenses
Other Operating Cash Flow
Cash from Operating Activities	121	63.4	98.9	23.3	144
Capital Expenditures	-33.1	-69.5	-102	-129	-42
Purchase of Fixed Assets
Other Investing Cash Flow Items	35.1	5.79	257	45	32.8
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	2	-63.7	156	-84.5	-9.11
Financing Cash Flow Items	-3.86	-1.86	-0.056	1.89	-3.31
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-38.2	-74.8	-192	-30.9	-87.9
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	85.5	-75.3	62.7	-92.1	46.7